| scholarly article | Q13442814 |
| P50 | author | Roger Pertwee | Q29643420 |
| P2093 | author name string | S R Fernando | |
| P2860 | cites work | (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability | Q28244400 |
| Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
| Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase | Q28305612 | ||
| SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
| Factors influencing the release of acetylcholine from the myenteric plexus of the ileum of the guinea-pig and rabbit | Q35177860 | ||
| Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine | Q35872513 | ||
| Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine | Q35874121 | ||
| Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2. | Q41214023 | ||
| Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations | Q46551529 | ||
| The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. | Q52754983 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 1716-1720 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist | |
| P478 | volume | 121 |
| Q34472174 | 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
| Q36943231 | A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects |
| Q28185158 | An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors |
| Q44570476 | Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors |
| Q48405803 | Cannabis and endogenous cannabinoid systems. |
| Q36514529 | Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination. |
| Q36803312 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics |
| Q34998022 | Endocannabinoid hydrolases |
| Q48290397 | Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors |
| Q35028614 | Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK |
| Q44618356 | Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells |
| Q37093006 | Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia. |
| Q33704434 | Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders |
| Q37444504 | Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons |
| Q37325801 | Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. |
| Q36914902 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase |
| Q40375894 | PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS. |
| Q36865744 | Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase |
| Q90083272 | Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist |
| Q36477479 | Recent progress in cannabinoid research |
| Q27667312 | Reversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting Analgesics |
| Q35048741 | Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2 |
| Q28346456 | Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens |
| Q36865750 | Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase |
| Q36341688 | The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids |
| Q33644120 | α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain |
Search more.